Search results
Teva Pharmaceutical to Face FTC Investigation Over Patents
Bloomberg· 4 days agoTeva Pharmaceutical Industries Ltd. is being investigated by the US Federal Trade Commission over...
Victoza: Generic Ozempic-Like GLP-1 Drug Now Available in U.S.
Healthline· 2 days agoTeva Pharmaceuticals is launching the first-ever generic GLP-1 drug in the United States. Victoza,...
FTC starts probe into Teva about some products' patents, Washington Post reports
Reuters via Yahoo Canada News· 4 days agoThe FTC last week ordered Teva to provide internal communications, analysis and financial data...
US DOJ drops Viatris unit Mylan from industry-wide antitrust probe
Reuters via Yahoo Canada News· 3 days agoMylan and several major drugmakers such as Israel's Teva Pharmaceutical Industries and India's Sun ...
Drugmakers Resist FTC, Lawmaker Efforts to Remove Drug Patents
Bloomberg Law· 4 days agoMajor pharmaceutical companies are resisting calls from the Biden administration and Democratic lawmakers to curb patenting practices on high-cost drugs, putting pressure ...
Treasuries Get Hit as US Election Risks in Focus: Markets Wrap
Bloomberg via Yahoo Finance Canada· 4 days ago(Bloomberg) -- The world’s biggest bond market got hit as traders weighed the potential economic...
Increasing Demand Customized Treatment is likely to Boost Necrotizing Fasciitis Treatment Market...
Digital Journal· 2 days agoNecrotizing Fasciitis Treatment Industry is Expected to Reach USD 4.5 Billion by 2034 And Grow at A CAGR of 5.2%. NEWARK, DE / ACCESSWIRE / July 3, 2024 / The necrotizing fasciitis treatment ...
NurExone’s ExoPTEN Being Studied as Glaucoma Treatment for US$3.4 Billion Market
Digital Journal· 7 days agoNurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company, is pleased to announce a pre-clinical study to explore ...